- Home
- CRGX vs HAIN Comparison
CRGX vs HAIN Comparison
Compare CRGX & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- HAIN
- Stock Information
- Founded
- CRGX 2021
- HAIN 1993
- Country
- CRGX United States
- HAIN United States
- Employees
- CRGX N/A
- HAIN N/A
- Industry
- CRGX
- HAIN Packaged Foods
- Sector
- CRGX
- HAIN Consumer Staples
- Exchange
- CRGX Nasdaq
- HAIN Nasdaq
- Market Cap
- CRGX 190.0M
- HAIN 162.5M
- IPO Year
- CRGX 2023
- HAIN 1993
- Fundamental
- Price
- CRGX $4.25
- HAIN $1.87
- Analyst Decision
- CRGX Hold
- HAIN Hold
- Analyst Count
- CRGX 7
- HAIN 9
- Target Price
- CRGX $4.67
- HAIN $4.56
- AVG Volume (30 Days)
- CRGX 569.8K
- HAIN 4.2M
- Earning Date
- CRGX 05-08-2025
- HAIN 05-07-2025
- Dividend Yield
- CRGX N/A
- HAIN N/A
- EPS Growth
- CRGX N/A
- HAIN N/A
- EPS
- CRGX N/A
- HAIN N/A
- Revenue
- CRGX N/A
- HAIN $1,615,231,000.00
- Revenue This Year
- CRGX $58.18
- HAIN N/A
- Revenue Next Year
- CRGX N/A
- HAIN N/A
- P/E Ratio
- CRGX N/A
- HAIN N/A
- Revenue Growth
- CRGX N/A
- HAIN N/A
- 52 Week Low
- CRGX $3.00
- HAIN $1.30
- 52 Week High
- CRGX $25.45
- HAIN $9.43
- Technical
- Relative Strength Index (RSI)
- CRGX 53.57
- HAIN 37.82
- Support Level
- CRGX $3.78
- HAIN $1.82
- Resistance Level
- CRGX $4.27
- HAIN $2.04
- Average True Range (ATR)
- CRGX 0.18
- HAIN 0.15
- MACD
- CRGX 0.03
- HAIN 0.05
- Stochastic Oscillator
- CRGX 88.79
- HAIN 46.15
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.